ICP DAS - BMP's Medical-Grade TPU Takes Center Stage at Top Global Medical & Plastic Exhibitions

December 12, 2023 12:51 AM PST | By Cision

Google News:

ICP DAS - BMP's Medical-Grade TPU Takes Center Stage at Top Global Medical & Plastic Exhibitions — Image source: Kalkine Media

Recent News

Global Markets React to Diplomatic Updates, U.S. Indices Dip, Nikkei 2...

Arhaus Inc. (NASDAQ:ARHS): Climbing the Nasdaq Companies by Market Cap

Steven Madden (NASDAQ:SHOO) A Key Player Among the Biggest NASDAQ Stoc...

Nevro Corp A Russell 1000 Neuromodulation Leader in Chronic Pain Relie...

HSINCHU, Dec. 12, 2023 /PRNewswire/ -- ICP DAS (3577-TW) New Business Unit, ICP DAS – BMP, actively ramps up medical-grade TPU (thermoplastic polyurethane) development and production as well as international marketing. The company's participation at COMPAMED and IPF Japan has been a resounding success, highlighted by a notable increase in post-event product inquiries.

ICP DAS – BMP’s Medical-Grade TPU Takes Center Stage at Top Global Medical & Plastic Exhibitions

ICP DAS – BMP, Asia's first medical-grade TPU supplier, offers a complete range of Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series) products. All TPU series are available in different hardness. ICP DAS' 30-year expertise in industrial automation empowers ICP DAS – BMP to build and deploy a smart factory, optimizing parameter control and management.

The high-quality TPUs, with superior processability and stability, have been selected by existing and new customers to manufacture various electromedical devices and advanced catheters used in cardiovascular, gastrointestinal, and cancer treatment procedures. Other applications include coating of guidewires and ophthalmic consumables.

Using in situ polymerization, ICP DAS – BMP has developed TPUs loaded with varying percentages of radiopaque fillers (Tungsten/Barium Sulfate) to meet each application's specific needs. We provide all TPU series with 20% and 40% loading of Barium Sulfate. This year, the new products include ALC-B30 loaded with 30% Barium Sulfate, and ARP-W and ALP-W series loaded with 30-80% Tungsten. The Tungsten-filled series is well-suited for the production of small-dimension or thin-walled devices.

Next, ICP DAS – BMP is extending its TPU portfolio by bringing out the EARP and EALP series. The Engineering TPUs feature high hardness, excellent heat resistance, and superior processability, ideal for manufacturing medical devices requiring high hardness and outstanding physical properties.

Quality management, holistic after-sales services, short delivery times, and flexible options for small order quantities enable ICP DAS – BMP to maintain a strong competitive edge in the global market.

About ICP DAS - BMP

ICP DAS - BMP, an ISO 13485-certified TPU manufacturer and supplier in Taiwan, offer USP Class VI and/or ISO 10993 certified TPU series: ISO 10993-4 for hemocompatibility testing, ISO 10993-5 for cytotoxicity testing, ISO 10993-6 for local effects after implantation, ISO 10993-10 for skin sensitization testing, ISO 10993-11 for systemic toxicity testing, and ISO 10993-23 for irritation testing. Our products also comply with REACH and RoHS.

For more details, please visit our website: https://bmp.icpdas.com/

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.